PL2027103T3 - Nowe, chiralne związki pośrednie, sposób ich wytwarzania i ich zastosowanie w wytwarzaniu tolterodyny, fesoterodyny lub ich aktywnych metabolitów - Google Patents

Nowe, chiralne związki pośrednie, sposób ich wytwarzania i ich zastosowanie w wytwarzaniu tolterodyny, fesoterodyny lub ich aktywnych metabolitów

Info

Publication number
PL2027103T3
PL2027103T3 PL07725866T PL07725866T PL2027103T3 PL 2027103 T3 PL2027103 T3 PL 2027103T3 PL 07725866 T PL07725866 T PL 07725866T PL 07725866 T PL07725866 T PL 07725866T PL 2027103 T3 PL2027103 T3 PL 2027103T3
Authority
PL
Poland
Prior art keywords
fesoterodine
tolterodine
manufacture
producing
same
Prior art date
Application number
PL07725866T
Other languages
English (en)
Inventor
Claus Meese
Original Assignee
Ucb Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Gmbh filed Critical Ucb Pharma Gmbh
Publication of PL2027103T3 publication Critical patent/PL2027103T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/12Formation of amino and carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
PL07725866T 2006-06-12 2007-06-06 Nowe, chiralne związki pośrednie, sposób ich wytwarzania i ich zastosowanie w wytwarzaniu tolterodyny, fesoterodyny lub ich aktywnych metabolitów PL2027103T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06012052 2006-06-12
EP07725866.3A EP2027103B1 (en) 2006-06-12 2007-06-06 New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
PCT/EP2007/005008 WO2007144097A1 (en) 2006-06-12 2007-06-06 New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof

Publications (1)

Publication Number Publication Date
PL2027103T3 true PL2027103T3 (pl) 2014-12-31

Family

ID=36764900

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07725866T PL2027103T3 (pl) 2006-06-12 2007-06-06 Nowe, chiralne związki pośrednie, sposób ich wytwarzania i ich zastosowanie w wytwarzaniu tolterodyny, fesoterodyny lub ich aktywnych metabolitów

Country Status (16)

Country Link
US (3) US7982058B2 (pl)
EP (1) EP2027103B1 (pl)
JP (1) JP5220737B2 (pl)
KR (2) KR101488740B1 (pl)
CN (1) CN101466695B (pl)
AU (1) AU2007260267B2 (pl)
BR (1) BRPI0712842A2 (pl)
CA (1) CA2647990C (pl)
DK (1) DK2027103T3 (pl)
EA (1) EA018376B1 (pl)
ES (1) ES2464868T3 (pl)
MX (1) MX2008015973A (pl)
PL (1) PL2027103T3 (pl)
PT (1) PT2027103E (pl)
SI (1) SI2027103T1 (pl)
WO (1) WO2007144097A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101466695B (zh) * 2006-06-12 2012-06-27 施瓦茨制药有限公司 新手性中间体、其制备方法及其在托特罗定、非索罗定或其活性代谢物制备中的用途
EP2364966A1 (en) 2010-03-09 2011-09-14 LEK Pharmaceuticals d.d. Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine
WO2011158257A1 (en) 2010-06-18 2011-12-22 Panacea Biotec Ltd Preparation process of fesoterodine and intermediates
IT1403094B1 (it) * 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
CN103193747A (zh) * 2013-04-18 2013-07-10 中国药科大学 一种富马酸弗斯特罗定中间体的制备方法
KR20230042887A (ko) 2021-09-23 2023-03-30 주식회사 두비컴퓨팅 서버 랙

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8800207D0 (sv) 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
SE9701144D0 (sv) 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Schwarz Pharma Ag, 40789 Monheim Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen
SE9904850D0 (sv) 1999-12-30 1999-12-30 Pharmacia & Upjohn Ab Novel process and intermediates
DE10028443C1 (de) * 2000-06-14 2002-05-29 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
WO2007138440A1 (en) * 2006-05-24 2007-12-06 Pfizer Limited Process for the production of benzopyran-2-ol derivatives
CN101466695B (zh) * 2006-06-12 2012-06-27 施瓦茨制药有限公司 新手性中间体、其制备方法及其在托特罗定、非索罗定或其活性代谢物制备中的用途

Also Published As

Publication number Publication date
CN101466695B (zh) 2012-06-27
PT2027103E (pt) 2014-05-02
AU2007260267B2 (en) 2012-09-06
KR20140010198A (ko) 2014-01-23
US20140228434A1 (en) 2014-08-14
EA018376B1 (ru) 2013-07-30
KR101488740B1 (ko) 2015-02-03
JP2009539901A (ja) 2009-11-19
SI2027103T1 (sl) 2014-07-31
JP5220737B2 (ja) 2013-06-26
EP2027103A1 (en) 2009-02-25
CA2647990A1 (en) 2007-12-21
US8742140B2 (en) 2014-06-03
US7982058B2 (en) 2011-07-19
KR20090016451A (ko) 2009-02-13
AU2007260267A1 (en) 2007-12-21
EA200900008A1 (ru) 2009-06-30
DK2027103T3 (da) 2014-04-22
US20110245338A1 (en) 2011-10-06
MX2008015973A (es) 2009-01-12
BRPI0712842A2 (pt) 2012-07-24
US20090192224A1 (en) 2009-07-30
CN101466695A (zh) 2009-06-24
CA2647990C (en) 2014-02-04
WO2007144097A1 (en) 2007-12-21
US9309215B2 (en) 2016-04-12
ES2464868T3 (es) 2014-06-04
EP2027103B1 (en) 2014-02-26

Similar Documents

Publication Publication Date Title
PL2144879T3 (pl) Pirydynokarboksamidy, zawierający je środek ochrony roślin użytkowych i sposób ich wytwarzania i zastosowanie
PT2027103E (pt) Novo intermediário quiral, processo para a sua produção e sua utilização no fabrico de tolterodina, fesoterodina ou o seu metabolito activo
PL2235098T3 (pl) Spieniona, szczególnie wrażliwa na nacisk masa klejowa, sposób jej wytwarzania oraz jej zastosowanie
IL185804A0 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
EP2151500A4 (en) BRANCHED A-GLUCAN, THESE PRODUCING A-GLUCOSYLTRANSFERASE, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
EP2198962A4 (en) CATALYST, ITS MANUFACTURING METHOD AND USE
HK1137156A1 (en) Headgear and process for producing the same
HK1118247A1 (en) Catalyst-coated support, method for producing the same, reactor comprising the same and use thereof
EP1982767A4 (en) HONEYCOMB SEGMENT, HONEYCOMB STRUCTURE AND METHOD FOR PRODUCING THE SAME
EP1902626A4 (en) FLAVOR AGENT WITH COOKED OIL AROMA AND PROCESS FOR PRODUCING THE SAME
EP2037433A4 (en) DISPLAY AND PROCESS FOR ITS MANUFACTURE
PL2234947T3 (pl) Produkt oparty na glicerynie, sposób jego otrzymywania i jego zastosowanie do wytwarzania dichloropropanolu
EP1849778A4 (en) PROCESS FOR PRODUCING OPTICALLY ACTIVE EPOXY COMPOUND, COMPLEX FOR USE IN THE METHOD AND PROCESS FOR PRODUCING THE SAME
ZA200900321B (en) Beverage precursor and process for the manufacture thereof
EP1921049A4 (en) POLYCRYSTALLINE DIAMOND WITH HIGH HARDNESS AND METHOD OF MANUFACTURING THEREOF
EP2251081A4 (en) CATALYST, PROCESS FOR ITS MANUFACTURE AND USE
PL2274092T3 (pl) Nowe katalizatory i ich zastosowanie przy wytwarzaniu poliuretanów
EP1797020A4 (en) GUANIDINE POLYSACCHARIDES, THEIR USE AS ABSORBENTS AND PROCESS FOR THE PRODUCTION THEREOF
PL2806044T3 (pl) Stop miedzi i cynku, sposób jego wytwarzania i zastosowanie
EP2189486A4 (en) MELT-LOW VISCOSITY POLYGLYCOLIC ACID, PROCESS FOR PRODUCTION THEREOF, AND USE OF MELT-LOW VISCOSITY POLYGLYCOLIC ACID
EP2000286A4 (en) CONTINUOUS STRETCH FILM, PROCESS FOR PRODUCTION AND USE OF THE STRETCH FILM
EP2127741A4 (en) WATER ABSORBING SUBSTANCE AND PROCESS FOR PRODUCING THE SAME
EP2247623A4 (en) NEW CELLULOSE DERIVATIVES, METHOD OF MANUFACTURING THEREOF AND USE THEREOF
EP2062601A4 (en) FOAM AND PROCESS FOR PRODUCING THE SAME
EP2275419A4 (en) LUBIPROSTONE CRYSTAL, PREPARATION METHOD AND USE THEREOF